WallStreetZenWallStreetZen

NASDAQ: BNTX
Biontech Se Earnings & Revenue

Open Broker Account

BNTX past earnings growth

How has BNTX's earnings growth performed historically?
Company
17.07%
Industry
15.98%
Market
40.77%
BNTX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
BNTX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
BNTX's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

BNTX past revenue growth

How has BNTX's revenue growth performed historically?
Company
14.43%
Industry
117.46%
Market
174.68%
BNTX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BNTX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BNTX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BNTX earnings and revenue history

Current Revenue
$18.6B
Current Earnings
$10.3B
Current Profit Margin
55.6%

BNTX Return on Equity

Current Company
65.5%
Current Industry
-9.7%
Current Market
-8.3%
BNTX's Return on Equity (65.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BNTX announces earnings.

BNTX Return on Assets

Current Company
51.6%
Current Industry
0.7%
BNTX is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BNTX Return on Capital Employed

Current Company
77.6%
Current Industry
11.4%
BNTX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BNTX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BNTX$18.20B$14.35B$10.12B+487.71%+17.07%
GMAB$1.59B$1.07B$747.88M+123.86%+128.11%
ALNY$960.92M-$935.29M-$1.18B+69.13%N/A
RPRX$2.25B$694.80M$506.82M+5.80%-41.24%
SGEN$1.86B-$552.70M-$636.77M+32.41%N/A

Biontech Se Earnings & Revenue FAQ

What were BNTX's earnings last quarter?

On Invalid Date, Biontech Se (NASDAQ: BNTX) reported Q3 2022 earnings per share (EPS) of $7.43, up 51.94% year over year. Total Biontech Se earnings for the quarter were $1.78 billion. In the same quarter last year, Biontech Se's earnings per share (EPS) was $15.46.

If you're new to stock investing, here's how to buy Biontech Se stock.

What was BNTX's earnings growth in the past year?

As of Q4 2022, Biontech Se's earnings has grown 17.07% year over year. This is 1.09 percentage points higher than the US Biotechnology industry earnings growth rate of 15.98%. Biontech Se's earnings in the past year totalled $10.12 billion.

What was BNTX's revenue last quarter?

On Invalid Date, Biontech Se (NASDAQ: BNTX) reported Q3 2022 revenue of $3.46 billion up 51.67% year over year. In the same quarter last year, Biontech Se's revenue was $7.16 billion.

What was BNTX's revenue growth in the past year?

As of Q4 2022, Biontech Se's revenue has grown 14.43% year over year. This is 103.03 percentage points lower than the US Biotechnology industry revenue growth rate of 117.46%. Biontech Se's revenue in the past year totalled $18.20 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.